Susquehanna International Group, LLP United Therapeutics Corp Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in United Therapeutics Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 23,266 shares of UTHR stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,266

Previous 6,641 250.34%

Holding current value

$10.1 Million

Previous $2.05 Million 226.58%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$276.47 - $328.4 $4.6 Million - $5.46 Million	16,625 Added 250.34%	23,266 $6.69 Million
Q1 2025 May 14, 2025	SELL	$304.42 - $380.78 $42,314 - $52,928	-139 Reduced 2.05%	6,641 $2.05 Million
Q4 2024 Feb 14, 2025	SELL	$348.66 - $410.0 $4.41 Million - $5.19 Million	-12,656 Reduced 65.12%	6,780 $2.39 Million
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $941,829 - $1.1 Million	3,028 Added 18.45%	19,436 $6.96 Million
Q2 2024 Aug 15, 2024	SELL	$228.26 - $319.04 $4.17 Million - $5.83 Million	-18,273 Reduced 52.69%	16,408 $5.23 Million
Q1 2024 May 07, 2024	BUY	$210.76 - $249.51 $2.79 Million - $3.3 Million	13,242 Added 61.77%	34,681 $7.97 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $9.05 Million - $10.8 Million	-42,100 Reduced 66.26%	21,439 $4.71 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $1.2 Million - $1.41 Million	5,686 Added 9.83%	63,539 $14.4 Million
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $6.1 Million - $6.93 Million	-29,731 Reduced 33.95%	57,853 $12.8 Million
Q1 2023 May 16, 2023	BUY	$212.99 - $276.17 $13.1 Million - $17 Million	61,403 Added 234.53%	87,584 $19.6 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $1.53 Million - $2.08 Million	-7,417 Reduced 22.08%	26,181 $7.28 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $6.48 Million - $7.79 Million	31,889 Added 1865.94%	33,598 $7.04 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $1.05 Million - $1.45 Million	-6,006 Reduced 77.85%	1,709 $403,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $427,529 - $550,519	-2,573 Reduced 25.01%	7,715 $1.38 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $7.18 Million - $8.42 Million	-38,963 Reduced 79.11%	10,288 $2.22 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $7.63 Million - $9.11 Million	42,419 Added 620.89%	49,251 $9.09 Million
Q2 2021 Aug 11, 2021	SELL	$170.47 - $211.93 $4.59 Million - $5.71 Million	-26,952 Reduced 79.78%	6,832 $1.23 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $1.37 Million - $1.55 Million	8,875 Added 35.63%	33,784 $5.65 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $1.63 Million - $2.43 Million	15,992 Added 179.34%	24,909 $3.78 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $205,494 - $249,164	2,057 Added 29.99%	8,917 $901,000
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $751,935 - $1.02 Million	-8,108 Reduced 54.17%	6,860 $830,000
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $812,477 - $1.18 Million	-10,234 Reduced 40.61%	14,968 $1.42 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $3.33 Million - $4.05 Million	-42,516 Reduced 62.78%	25,202 $2.22 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $1.49 Million - $1.71 Million	19,931 Added 41.71%	67,718 $5.4 Million
Q2 2019 Aug 16, 2019	SELL	$76.06 - $120.81 $1.82 Million - $2.89 Million	-23,952 Reduced 33.39%	47,787 $3.73 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $8.51 Million - $10.9 Million	71,739	71,739 $10.6 Million

Others Institutions Holding UTHR

# of Institutions

747

Shares Held

43.9M

Call Options Held

340K

Put Options Held

318K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $19.7B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP United Therapeutics Corp Transaction History